Listen to members of the writing group for the new AHA statement on the clinical management of stable coronary artery disease in patients with T2D. Dr. Suzanne Arnold, Chair, and fellow writing group members, Dr. Prakash Deedwania and Dr. Mikhail Kosiborod will review highlights from the statement, including recent clinical trials which uncovered several new drugs that not only reduce glucose but also improve cardiovascular and renal outcomes (Clinical Management of Stable Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus – AHA Scientific Statement).
2020 Episode 6 – Clinical Management of Stable Coronary Artery Disease in Patients with T2D
Prakash Deedwania, MD, FACC, FAHA, FESC is one of the most recognizable figures in the fields of diabetes, hypertension, heart failure, lipid disorders, ischemic heart disease, rhythm disorders, and preventive cardiology where he has authored numerous landmark clinical trials and several clinical practice guidelines. He is a respected leader of several national and international medical societies, having held various positions at the American Heart Association, the American College of Cardiology, and the National Health Lung & Blood Institute. Having published over a thousand medical manuscripts, Dr. Deedwania is also on the editorial board of the top medical journals including the Journal of the American College of Cardiology, American Journal of Cardiology, and Clinical Cardiology, among many others.
Suzanne V. Arnold, MD, MHA is an Associate Professor of Medicine at University of Missouri-Kansas City and a cardiologist at Saint Luke’s Mid America Heart Institute. She also completed a cardiovascular outcomes research fellowship through the American Heart Association. Her research centers on the long-term outcomes of patients with cardiovascular disease, with a particular focus on patients’ quality of life—how to best assess it, what factors influence it, and how to improve it. She was the recipient of several research awards, including the Burton Sobel Award for Excellence in Cardiovascular Research at Washington University in St. Louis and the American Heart Association Young Investigator Award.